Search results

• Adenomyoepithelioma with carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:57, 26 July 2017
• Solid papillary carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:46, 26 July 2017
• Encapsulated papillary carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:45, 26 July 2017
• Intraductal papillary carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:44, 26 July 2017
• Ductal carcinoma in situ
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:43, 26 July 2017
• Acinic cell carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:42, 26 July 2017
• Glycogen-rich clear cell carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:42, 26 July 2017
• Lipid-rich carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:41, 26 July 2017
• Sebaceous carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:40, 26 July 2017
• Inflammatory carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:35, 26 July 2017
• Oncocytic carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:39, 26 July 2017
• Invasive micropapillary carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:35, 26 July 2017
• Invasive papillary carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:34, 26 July 2017
• Carcinoma with neuroendocrine features
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:34, 26 July 2017
• Carcinoma with signet-ring-cell differentiation
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:32, 26 July 2017
• Mucinous carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:31, 26 July 2017
• Salivary gland/skin adnexal type tumors
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:29, 26 July 2017
• Carcinoma with apocrine differentiation
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:28, 26 July 2017
• Carcinoma with medullary features
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:27, 26 July 2017
• Metaplastic carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:25, 26 July 2017
• Cribriform carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:24, 26 July 2017
• Tubular carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 11:26, 26 July 2017
• Invasive lobular carcinoma
  ==Cancer Category/Type== Breast cancer
  3 KB (455 words) - 16:00, 28 June 2017
• Invasive ductal carcinoma
  ==Cancer Category/Type== Breast Cancer
  3 KB (455 words) - 16:01, 28 June 2017
• Anaplastic oligoastrocytoma, NOS
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 18:06, 13 July 2017
• Oligoastrocytoma, NOS
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 18:06, 13 July 2017
• Anaplastic oligodendroglioma, NOS
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 18:05, 13 July 2017
• Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 18:05, 13 July 2017
• Oligodendroglioma, NOS 69
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 18:03, 13 July 2017
• Glioblastoma, IDH-mutant
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 18:01, 13 July 2017
• Anaplastic astrocytoma, NOS
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 18:00, 13 July 2017
• Anaplastic astrocytoma, IDH-wildtype
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 17:59, 13 July 2017
• Anaplastic astrocytoma, IDH-mutant
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 17:59, 13 July 2017
• Diffuse astrocytoma, NOS
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 17:58, 13 July 2017
• Diffuse astrocytoma, IDH-wildtype
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 17:58, 13 July 2017
• Glioblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 17:56, 13 July 2017
• Choroid plexus carcinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 15:52, 28 June 2017
• Secondary tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:14, 23 August 2017
• Neuroectodermal tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:14, 23 August 2017
• Haematolymphoid tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:14, 23 August 2017
• Benign tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:13, 23 August 2017
• Malignant tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:13, 23 August 2017
• Tumours of bone and cartilage
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:13, 23 August 2017
• Benign soft tissue tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:13, 23 August 2017
• Borderline and LMP tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:12, 23 August 2017
• Malignant soft tissue tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:12, 23 August 2017
• Salivary gland-type adenomas
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:12, 23 August 2017
• Respiratory epithelial adenomatoid hamartoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:11, 23 August 2017
• Schneiderian papillomas
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:11, 23 August 2017
• Salivary gland-type carcinomas
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:10, 23 August 2017
• Neuroendocrine tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:10, 23 August 2017
• Benign epithelial tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:11, 23 August 2017
• Sinonasal undifferentiated carcinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:10, 23 August 2017
• Soft tissue tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:09, 23 August 2017
• Lymphoepithelial carcinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:08, 23 August 2017
• Adenocarcinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:09, 23 August 2017
• Germ cell tumours
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:09, 23 August 2017
• Squamous cell carcinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 16:08, 23 August 2017
• Astroblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 13:18, 8 August 2017
• Schwannoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 13:17, 8 August 2017
• Epithelioid glioblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 13:13, 8 August 2017
• Gliosarcoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 13:12, 8 August 2017
• Subependymal giant cell astrocytoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 13:06, 8 August 2017
• Anaplastic pleomorphic xanthoastrocytoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 13:08, 8 August 2017
• Subependymoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:59, 8 August 2017
• Myxopapillary ependymoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:57, 8 August 2017
• Anaplastic ependymoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:56, 8 August 2017
• Anaplastic ganglioglioma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:55, 8 August 2017
• Gangliocytoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:51, 8 August 2017
• Dysembryoplastic neuroepithelial tumor
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:49, 8 August 2017
• Craniopharyngioma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:45, 8 August 2017
• CNS metastatic tumors
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:44, 8 August 2017
• Medulloblastoma, histologically defined
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:41, 8 August 2017
• Medulloblastomas, genetically defined
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:40, 8 August 2017
• Medulloblastoma, classic
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:39, 8 August 2017
• Large cell / anaplastic medulloblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:38, 8 August 2017
• Medulloblastoma with extensive nodularity
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:36, 8 August 2017
• Desmoplastic/nodular medulloblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:35, 8 August 2017
• Embryonal tumor with multilayed rosettes, NOS
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:33, 8 August 2017
• Embryonal tumor with multilayed rosettes, C19MC altered
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:32, 8 August 2017
• CNS embryonal tumor with rhabdoid features
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:22, 8 August 2017
• Medulloblastoma, SHH-activated, TP53-mutant
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:06, 8 August 2017
• Medulloblastoma, SHH-activated, TP53-wild-type
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:07, 8 August 2017
• Medulloblastoma, non-WNT/non-SHH
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:10, 8 August 2017
• Medulloepithelioma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:10, 8 August 2017
• Atypical teratoid/rhabdoid tumor
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:12, 8 August 2017
• CNS neuroblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:12, 8 August 2017
• CNS ganglioneuroblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:20, 8 August 2017
• CNS embryonal tumor, NOS
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:21, 8 August 2017
• Medulloblastoma, NOS
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:02, 8 August 2017
• Immature teratoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:01, 8 August 2017
• Mature teratoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 12:00, 8 August 2017
• Choriocarcinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:59, 8 August 2017
• Yolk sac tumor
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:59, 8 August 2017
• Embryonal carcinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:58, 8 August 2017
• Mixed germ cell tumor
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:57, 8 August 2017
• Neurofibromatosis type 2
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:52, 8 August 2017
• Germinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:50, 8 August 2017
• Neurofibromatosis Type I
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:51, 8 August 2017
• Meningioma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:49, 8 August 2017
• Pineoblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:48, 8 August 2017
• Pineocytoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:47, 8 August 2017
• Atypical choroid plexus papilloma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:46, 8 August 2017
• Choroid plexus papilloma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:45, 8 August 2017
• Ependymoma, RELA fusion-positive
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:44, 8 August 2017
• Ependymoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:43, 8 August 2017
• Pilomyxoid astrocytoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (457 words) - 11:42, 8 August 2017
• Diffuse large B-cell lymphoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 16:13, 23 August 2017
• Gynecomastia
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 12:21, 26 July 2017
• Pseudoangiomatous stromal hyperplasia
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 12:21, 26 July 2017
• Radial scar and complex sclerosing lesion
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 12:16, 26 July 2017
• Desmoid-type fibromatosis
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 12:18, 26 July 2017
• Microglandular adenosis
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 12:02, 26 July 2017
• Tubular adenoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 12:03, 26 July 2017
• Myofibroblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (454 words) - 12:01, 26 July 2017
• Myeloid Neoplasms with Germ Line Predisposition
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (464 words) - 16:58, 16 April 2018
• Acute Myeloid Leukemia (AML) with UPD 13
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (464 words) - 19:51, 9 August 2017
• Melanoma skin Cancer
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (465 words) - 12:41, 15 May 2018
• KMT2A(MLL)-MLLT6
  One of several t(11;17) events that appear identical down the microscope. The KMT2A-MLLT6 ch Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with het
  693 bytes (96 words) - 09:37, 10 March 2016
• Myeloid Neoplasms with Germline Predisposition
  ==General Disease Overview / Description of Cancer Category== ...loid leukemia (AML) are driven by genomic alterations such as mutations in genes encoding transcription factors (''GATA-2'', ''RUNX1'', ''ETV6'', and ''CEBP
  8 KB (1,042 words) - 14:40, 12 December 2023
• Breast Cancer
  2 General Disease Overview / Description of Cancer Category ...ary risk associations in breast cancer according to National Comprehensive Cancer Network (NCCN) Guidelines (version 3.2019)'''
  3 KB (377 words) - 16:45, 11 July 2019
• Testpageblank
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (450 words) - 10:55, 8 April 2020
• MAP2K1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (576 words) - 20:25, 29 July 2018
• ZRSR2
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:30, 29 July 2018
• BCORL1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:37, 29 July 2018
• U2AF1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:29, 29 July 2018
• RAD21
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:27, 29 July 2018
• MYD88
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:25, 29 July 2018
• NOTCH1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:26, 29 July 2018
• NRAS
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:26, 29 July 2018
• PHF6
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:26, 29 July 2018
• PTPN11
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:27, 29 July 2018
• KRAS
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:24, 29 July 2018
• MPL
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:25, 29 July 2018
• KDM6A
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:24, 29 July 2018
• GATA1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:22, 29 July 2018
• GNAS
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:22, 29 July 2018
• CBL
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:38, 29 July 2018
• CBLB
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:38, 29 July 2018
• CSF3R
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:38, 29 July 2018
• BRAF
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:37, 29 July 2018
• CALR
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:37, 29 July 2018
• BCOR
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:30, 29 July 2018
• CUX1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:18, 29 July 2018
• RBM15
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:17, 29 July 2018
• MKL1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:18, 29 July 2018
• MLLT3
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 18:16, 29 July 2018
• STAG2
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:28, 29 July 2018
• SMC3
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:28, 29 July 2018
• SMC1A
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:28, 29 July 2018
• SF3B1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:27, 29 July 2018
• SETBP1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:27, 29 July 2018
• JAK1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:23, 29 July 2018
• JAK3
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:24, 29 July 2018
• HRAS
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (587 words) - 20:22, 29 July 2018
• Global Template
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  3 KB (480 words) - 08:41, 15 April 2021
• SUZ12
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  5 KB (719 words) - 16:30, 16 June 2019
• FOXP1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  5 KB (719 words) - 16:28, 16 June 2019
• ERG
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  5 KB (719 words) - 16:31, 16 June 2019
• ETS2
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  5 KB (719 words) - 16:31, 16 June 2019
• NUP214
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (591 words) - 18:24, 11 October 2020
• NF1
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  5 KB (717 words) - 14:37, 10 August 2023
• PTEN
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (636 words) - 18:15, 29 July 2018
• TCF3
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  5 KB (697 words) - 13:18, 26 January 2020
• DEK
  ==Cancer Category/Type== DEK is implicated in acute myeloid leukemia and is associated with t(6;9)(p23;q34.1) resulting in DEK-NUP214 fusion protein. The DEK protein bin
  4 KB (650 words) - 16:45, 19 February 2022
• RARA
  ==Cancer Category/Type== ...yeloid clone by dissociating the PML/RAR-alpha-RXR complex from the target genes and was found to have a synergistic action with ATRA [4].
  8 KB (1,102 words) - 14:48, 12 December 2023
• ANKRD26
  ==Cancer Category/Type== ...on Database (LOVD(3)) 15) TICdb - database of Translocation breakpoints In Cancer 16) GeneReviews, and 17) Any gene-specific databases.
  5 KB (769 words) - 13:44, 12 December 2023
• CHIC2
  ==Cancer Category/Type== EXAMPLE [[Germline Cancer Predisposition Genes]]
  4 KB (583 words) - 15:24, 15 July 2018
• CBFB
  ==Cancer Category/Type== inv(16)(p13;q22) or t(16)(p13;q22), (CBFB andMYH11) also translocation confer a favorable progn
  6 KB (780 words) - 10:41, 2 August 2018
• MYH11
  ==Cancer Category/Type== ..._CBFB::MYH11_fusion Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]'''
  6 KB (910 words) - 14:36, 12 December 2023
• Breast Cancer Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray
  ...cancer working group|url=https://pubmed.ncbi.nlm.nih.gov/32087595|journal=Cancer Genetics|volume=244|pages=11–20|doi=10.1016/j.cancergen.2020.02.002|issn= Abbreviations: TNBC, triple negative breast cancer; LOH, loss of heterozygosity.
  6 KB (894 words) - 17:42, 22 April 2021
• Acute myeloid leukemia with t(4;12)(q12;p13), CHIC2-ETV6
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  4 KB (553 words) - 10:02, 3 August 2017
• JAK2
  ==Cancer Category/Type== ...Medicine Knnowledgebase (Weill Cornell), 6) Cancer Index, 7) OncoKB, 8) My Cancer Genome, 9) UniProt, 10) Pfam, 11) GeneCards, 12) GeneReviews, and 13) Any g
  4 KB (615 words) - 14:31, 12 December 2023
• PML
  ==Cancer Category/Type== ...yeloid clone by dissociating the PML/RAR-alpha-RXR complex from the target genes and was found to have a synergistic action with ATRA [5].
  7 KB (998 words) - 14:45, 12 December 2023
• Translocation t(14;19)(q32;q13.3)
  Translocation t(14;19)(q32;q13.3): IGH/BCL3 It should not be confused with the t(14;19) rearrangement found in B-ALL involving the same breakpoints but targ
  4 KB (537 words) - 21:44, 20 July 2016
• TEST Gene Template
  ==Cancer Category/Type== 6) Cancer Index,
  5 KB (717 words) - 11:50, 11 April 2019
• RUNX1T1
  ==Cancer Category/Type== ...oid_leukaemia_with_RUNX1::RUNX1T1_fusion Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]'''
  7 KB (1,022 words) - 14:48, 12 December 2023
• GTS5:Familial adenomatous polyposis (APC)
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (804 words) - 13:34, 25 February 2024
• CNS5:Diffuse astrocytoma, MYB- or MYBL1-altered
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (806 words) - 13:50, 25 February 2024
• CNS5:Glioblastoma, IDH-wildtype
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (806 words) - 13:50, 25 February 2024
• CNS5:Astrocytoma, IDH-mutant
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (806 words) - 13:48, 25 February 2024
• BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (804 words) - 15:04, 6 October 2023
• STBT5:Ewing sarcoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (804 words) - 11:50, 25 February 2024
• Disease-Specific Template
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (806 words) - 12:47, 3 October 2023
• Mucoepidermoid Carcinoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (806 words) - 12:48, 3 October 2023
• STBT5:NTRK-rearranged spindle cell neoplasm (emerging)
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (807 words) - 11:47, 25 February 2024
• CNS5:Pleomorphic xanthoastrocytoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (807 words) - 13:54, 25 February 2024
• CNS5:Pilocytic astrocytoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (807 words) - 13:54, 25 February 2024
• FGFR1
  ==Cancer Category/Type== ...lia, but also as AML and they may even present as, or evolve to, precursor T or B lymphoblastic leukaemia/lymphoma with prominent eosinphils." (p.28).
  10 KB (1,469 words) - 17:05, 11 October 2018
• CNS5:Diffuse midline glioma, H3 K27-altered
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  6 KB (887 words) - 13:51, 25 February 2024
• KIT
  ==Cancer Category/Type== ..., hematopoietic and lymphoid cancers (13.8%), and Melanomas (7%) ([https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=kit see COSMIC]).
  7 KB (1,047 words) - 14:32, 12 December 2023
• CEBPA
  ==Cancer Category/Type== ...AAT/enhancer-binding proteins beta and gamma to modulate the expression of genes involved in cell cycle regulation. It coordinates proliferation arrest and
  7 KB (1,051 words) - 13:53, 12 December 2023
• HAEM5:Leukaemic non-nodal mantle cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,368 words) - 15:12, 22 December 2023
• HAEM5:EBV-positive inflammatory follicular dendritic cell sarcoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,391 words) - 18:27, 23 December 2023
• HAEM5:Hydroa vacciniforme lymphoproliferative disorder
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,389 words) - 18:22, 23 December 2023
• HAEM5:Systemic chronic active EBV disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,392 words) - 18:23, 23 December 2023
• DDX41
  ==Cancer Category/Type== ...urr. Biol. 9: 1373-1381, 1999.</ref><ref>Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adapto
  5 KB (787 words) - 14:00, 12 December 2023
• HAEM5:Diffuse large B-cell lymphoma associated with chronic inflammation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,434 words) - 10:50, 27 February 2024
• HAEM5:Nodal TFH cell lymphoma, NOS
  ...riginal page can be found at [[HAEM4:Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]]. ==Cancer Category / Type==
  10 KB (1,386 words) - 14:35, 13 December 2023
• HAEM5:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes
  {{DISPLAYTITLE:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes}} ==Cancer Category / Type==
  11 KB (1,530 words) - 14:34, 13 December 2023
• HAEM5:Fibrin-associated large B-cell lymphoma
  ...e 4th edition was Fibrin-Associated Diffuse Large B-cell Lymphoma and didn't have content. ==Cancer Category / Type==
  10 KB (1,435 words) - 11:55, 23 December 2023
• MDS/AML with CUX1 deletion or del(7q22)
  [[Category:Somatically Mutated Genes]] ...na, MD, M.D. Anderson Cancer Center and Min Fang, MD, PhD, Fred Hutchinson Cancer Research Center
  8 KB (1,195 words) - 21:24, 6 August 2016
• GTS5:Peutz-Jeghers syndrome (STK11)
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,489 words) - 13:37, 25 February 2024
• GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,489 words) - 13:38, 25 February 2024
• GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,489 words) - 13:43, 25 February 2024
• RUNX1
  ==Cancer Category/Type== ...oid_leukaemia_with_RUNX1::RUNX1T1_fusion Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]'''
  11 KB (1,545 words) - 14:48, 12 December 2023
• HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion
  ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3]]. ==Cancer Category / Type==
  10 KB (1,436 words) - 14:21, 13 December 2023
• BRST5:Polygenic Component of Breast Cancer Susceptibility
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,489 words) - 13:31, 29 February 2024
• Cowden syndrome
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,489 words) - 10:47, 29 January 2024
• GTS5:Li-Fraumeni syndrome (TP53)
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,489 words) - 13:39, 25 February 2024
• GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,489 words) - 13:41, 25 February 2024
• GTS5:Ataxia-telangiectasia syndrome (ATM)
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,489 words) - 13:42, 25 February 2024
• GTS5:PALB2-related cancer predisposition syndrome (PALB2)
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,494 words) - 16:44, 4 March 2024
• BRST5:Fibroadenoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,460 words) - 13:26, 29 February 2024
• HAEM5:Clonal haematopoiesis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  10 KB (1,501 words) - 18:38, 27 February 2024
• HAEM5:Monoclonal B-cell lymphocytosis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  9 KB (1,266 words) - 14:32, 13 December 2023
• HAEM5:RASopathies
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,506 words) - 14:39, 13 December 2023
• HAEM5:Splenic hamartoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:40, 13 December 2023
• HAEM5:Bloom syndrome
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:21, 13 December 2023
• HAEM5:Juvenile xanthogranuloma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:29, 13 December 2023
• HAEM5:Fanconi anaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:25, 13 December 2023
• HAEM5:Lymphomatoid granulomatosis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:30, 13 December 2023
• HAEM5:ALK-positive histiocytosis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:16, 13 December 2023
• HAEM5:Littoral cell angioma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:30, 13 December 2023
• HAEM5:IgG4-related disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:27, 13 December 2023
• HAEM5:Rosai-Dorfman Disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:39, 13 December 2023
• HAEM5:Erdheim-Chester disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:25, 13 December 2023
• HAEM5:Ataxia-telangiectasia syndrome
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:19, 13 December 2023
• HAEM5:Autoimmune lymphoproliferative syndrome
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:19, 13 December 2023
• HAEM5:Kikuchi-Fujimoto disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,509 words) - 14:29, 13 December 2023
• HAEM5:Cold agglutinin disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:23, 13 December 2023
• HAEM5:Unicentric Castleman disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:41, 13 December 2023
• HAEM5:Primary effusion lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:38, 13 December 2023
• HAEM5:Intranodal palisaded myofibroblastoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:29, 13 December 2023
• HAEM5:Myelodysplastic neoplasm, hypoplastic
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:33, 13 December 2023
• HAEM5:Alpha heavy chain disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,515 words) - 14:19, 13 December 2023
• HAEM5:Fibroblastic reticular cell tumour
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,515 words) - 14:25, 13 December 2023
• HAEM5:Duodenal-type follicular lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:24, 13 December 2023
• HAEM5:Interdigitating dendritic cell sarcoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,515 words) - 14:28, 13 December 2023
• HAEM5:Indeterminate dendritic cell tumour
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,515 words) - 14:28, 13 December 2023
• HAEM5:Subcutaneous panniculitis-like T-cell lymphoma
  {{DISPLAYTITLE:Subcutaneous panniculitis-like T-cell lymphoma}} ==Cancer Category / Type==
  11 KB (1,515 words) - 14:40, 13 December 2023
• HAEM5:Indolent T-lymphoblastic proliferation
  {{DISPLAYTITLE:Indolent T-lymphoblastic proliferation}} ==Cancer Category / Type==
  11 KB (1,512 words) - 14:28, 13 December 2023
• HAEM5:Clonal cytopenias of undetermined significance
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,518 words) - 14:23, 13 December 2023
• HAEM5:EBV-positive mucocutaneous ulcer
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,512 words) - 14:24, 13 December 2023
• HAEM5:Extranodal NK/T-cell lymphoma
  {{DISPLAYTITLE:Extranodal NK/T-cell lymphoma}} ==Cancer Category / Type==
  11 KB (1,515 words) - 14:25, 13 December 2023
• HAEM5:Monoclonal gammopathy of renal significance
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,518 words) - 14:32, 13 December 2023
• HAEM5:Mu heavy chain disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,515 words) - 14:32, 13 December 2023
• HAEM5:Idiopathic multicentric Castleman disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,515 words) - 14:27, 13 December 2023
• HAEM5:Peripheral T-cell lymphoma, NOS
  {{DISPLAYTITLE:Peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==
  11 KB (1,515 words) - 14:36, 13 December 2023
• HAEM5:Severe mosquito bite allergy
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,515 words) - 14:39, 13 December 2023
• HAEM5:Myelodysplastic neoplasm with low blasts
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,518 words) - 14:33, 13 December 2023
• HAEM5:Acute myeloid leukaemia with other defined genetic alterations
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,527 words) - 14:18, 13 December 2023
• HAEM5:Acute myeloid leukaemia with NUP98 rearrangement
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,521 words) - 14:17, 13 December 2023
• HAEM5:Mediastinal grey zone lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,515 words) - 14:31, 13 December 2023
• HAEM5:Transformations of indolent B-cell lymphomas
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,520 words) - 11:21, 23 December 2023
• HAEM5:Acute leukaemia of ambiguous lineage, NOS
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,521 words) - 14:16, 13 December 2023
• HAEM5:Primary mediastinal large B-cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,518 words) - 14:39, 13 December 2023
• HAEM5:T-lymphoblastic leukaemia / lymphoma, NOS
  {{DISPLAYTITLE:T-lymphoblastic leukaemia / lymphoma, NOS}} ==Cancer Category / Type==
  11 KB (1,517 words) - 15:33, 22 December 2023
• HAEM5:IgM monoclonal gammopathy of undetermined significance
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,521 words) - 14:27, 13 December 2023
• HAEM5:Myeloid/lymphoid neoplasm with FLT3 rearrangement
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,524 words) - 15:52, 20 December 2023
• HAEM5:Fluid overload-associated large B-cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,518 words) - 14:26, 13 December 2023
• HAEM5:Nodal TFH cell lymphoma, follicular-type
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,518 words) - 14:35, 13 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,517 words) - 15:33, 22 December 2023
• HAEM5:Nodular lymphocyte predominant Hodgkin lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,518 words) - 14:36, 13 December 2023
• HAEM5:Acute leukaemia of ambiguous lineage with other defined genetic alterations
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,533 words) - 14:16, 13 December 2023
• HAEM5:EBV-positive diffuse large B-cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,518 words) - 14:24, 13 December 2023
• HAEM5:Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,524 words) - 14:34, 13 December 2023
• HAEM5:Primary cutaneous peripheral T-cell lymphoma, NOS
  {{DISPLAYTITLE:Primary cutaneous peripheral T-cell lymphoma, NOS}} ==Cancer Category / Type==
  11 KB (1,521 words) - 14:38, 13 December 2023
• HAEM5:Primary cutaneous gamma/delta T-cell lymphoma
  {{DISPLAYTITLE:Primary cutaneous gamma/delta T-cell lymphoma}} ==Cancer Category / Type==
  11 KB (1,521 words) - 14:38, 13 December 2023
• HAEM5:T-cell/histiocyte-rich large B-cell lymphoma
  {{DISPLAYTITLE:T-cell/histiocyte-rich large B-cell lymphoma}} ==Cancer Category / Type==
  11 KB (1,518 words) - 14:41, 13 December 2023
• HAEM5:KSHV/HHV8-positive germinotropic lymphoproliferative disorder
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,521 words) - 14:29, 13 December 2023
• HAEM5:Non-IgM monoclonal gammopathy of undetermined significance
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,521 words) - 14:36, 13 December 2023
• HAEM5:Myelodysplastic neoplasm with low blasts and SF3B1 mutation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,530 words) - 14:33, 13 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,529 words) - 15:31, 22 December 2023
• HAEM5:Sclerosing angiomatoid nodular transformation (SANT) of spleen
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,524 words) - 14:39, 13 December 2023
• HAEM5:Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,530 words) - 14:31, 13 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,527 words) - 14:20, 13 December 2023
• HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,527 words) - 14:21, 13 December 2023
• HAEM5:KSHV/HHV8-positive diffuse large B-cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,524 words) - 14:29, 13 December 2023
• HAEM5:Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,527 words) - 14:28, 13 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  13 KB (1,759 words) - 14:19, 13 December 2023
• HAEM5:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder
  {{DISPLAYTITLE:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder}} ==Cancer Category / Type==
  11 KB (1,527 words) - 14:38, 13 December 2023
• HAEM5:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,530 words) - 14:39, 13 December 2023
• HAEM5:Primary cutaneous diffuse large B-cell lymphoma, leg type
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,527 words) - 14:38, 13 December 2023
• HAEM5:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma
  ...AYTITLE:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma}} ==Cancer Category / Type==
  11 KB (1,530 words) - 14:37, 13 December 2023
• HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis
  {{DISPLAYTITLE:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis}} ==Cancer Category / Type==
  11 KB (1,530 words) - 14:37, 13 December 2023
• HAEM5:Plasmacytoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,536 words) - 14:37, 13 December 2023
• HAEM5:Hyperplasias arising in immune deficiency/dysregulation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,539 words) - 14:27, 13 December 2023
• HAEM5:Lymphomas arising in immune deficiency / dysregulation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,545 words) - 14:30, 13 December 2023
• HAEM5:Inborn error of immunity-associated lymphoid proliferations and lymphomas
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,556 words) - 14:28, 13 December 2023
• ETV6
  ==Cancer Category/Type== ...substitution mutations, is found at a low level in many cancers ([https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=etv6 see COSMIC]); it is more prominen
  9 KB (1,371 words) - 14:18, 12 December 2023
• BCR
  ==Cancer Category/Type== ...ith Chronic Myeloid Leukemia have a Philadelphia chromosome resulting from t(9;22)(q34.1;q11.2), which is a reciprocal translocation between chromosome
  12 KB (1,749 words) - 13:50, 12 December 2023
• HAEM5:Myeloid neoplasms associated with germline predisposition
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,601 words) - 15:20, 20 December 2023
• HAEM5:Primary cutaneous marginal zone lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  11 KB (1,576 words) - 14:40, 6 March 2024
• HAEM5:Intestinal T-cell lymphoma, NOS
  {{DISPLAYTITLE:Intestinal T-cell lymphoma, NOS}} ...mplate on 2023-12-07. The original page can be found at [[HAEM4:Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]].
  13 KB (1,756 words) - 14:28, 13 December 2023
• Test
  '''Cancer Category/Type''' '''Cancer Sub-Classification/Subtype'''
  7 KB (872 words) - 15:02, 12 December 2023
• TP53
  ==Cancer Category/Type== Nearly universal involvement in diverse cancer types.
  11 KB (1,625 words) - 18:14, 5 January 2019
• HAEM5:Acute myeloid leukaemia without maturation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  14 KB (2,002 words) - 14:18, 13 December 2023
• BRST5:Secretory Carcinoma
  Hui Chen, MD, PhD, The University of Texas MD Anderson Cancer Center ==Cancer Category/Type==
  9 KB (1,336 words) - 16:42, 16 April 2024
• HAEM5:Follicular dendritic cell sarcoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  14 KB (1,992 words) - 14:26, 13 December 2023
• HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
  ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1]]. Cancer Category/Type
  14 KB (1,917 words) - 14:20, 13 December 2023
• Testpage
  [[File:T(6;9)(p23;q34).png]] ==Cancer Category/Type==
  10 KB (1,452 words) - 10:55, 12 September 2022
• HAEM5:Acute myeloid leukaemia with maturation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (2,064 words) - 14:18, 13 December 2023
• HAEM5:Diffuse large B-cell lymphoma, NOS
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (2,127 words) - 14:23, 13 December 2023
• HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement
  ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged]]. ==Cancer Category / Type==
  12 KB (1,796 words) - 14:21, 13 December 2023
• HAEM5:Primary large B-cell lymphoma of immune-privileged sites
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (2,146 words) - 12:07, 23 December 2023
• HAEM5:Mixed-phenotype acute leukaemia, rare types
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  16 KB (2,256 words) - 14:31, 13 December 2023
• STBT5:CIC-rearranged sarcoma
  ...ssue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). <nowiki>htt !Chromosomal Rearrangement!!Genes in Fusion (5’ or 3’ Segments)!!Pathogenic Derivative!!Prevalence
  13 KB (1,889 words) - 14:19, 14 March 2024
• How to Curate a Gene Page
  Thank you for volunteering to help curate the Compendium of Cancer Genome Aberrations (CCGA)! Your help will make this resource a valuable to .... The CCGA is interested in the curation of genes/mutations that arise in cancer. However, the dividing line between "Gene/Protein/Mutation" information an
  23 KB (3,717 words) - 14:25, 12 December 2023
• HAEM5:Primary myelofibrosis
  T. Niroshi Senaratne, UCLA ==Cancer Category / Type==
  16 KB (2,266 words) - 14:39, 13 December 2023
• ABL1
  ==Cancer Category/Type== ...ith Chronic Myeloid Leukemia have a Philadelphia chromosome resulting from t(9;22)(q34.1;q11.2), which is a reciprocal translocation between chromosome
  12 KB (1,695 words) - 13:43, 12 December 2023
• HAEM5:Myeloid neoplasm post cytotoxic therapy
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  17 KB (2,323 words) - 14:34, 13 December 2023
• HAEM5:Follicular lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  18 KB (2,507 words) - 15:34, 20 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion
  ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1]]. ==Cancer Category / Type==
  15 KB (2,139 words) - 14:20, 13 December 2023
• HAEM5:KSHV/HHV8-associated multicentric Castleman disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  14 KB (1,944 words) - 14:29, 13 December 2023
• HAEM5:Acute myelomonocytic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (2,084 words) - 14:18, 13 December 2023
• Chromophobe renal cell carcinoma
  ...>Diaz JI, Mora LB, Hakam A. The Mainz Classification of Renal Cell Tumors. Cancer Control. 1999 Nov;6(6):571-579</ref> ...ton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 8;26(3):319-30.</ref>
  3 KB (421 words) - 11:29, 22 August 2016
• Acute Myeloid Leukemia (AML) with Mutated FLT3
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  9 KB (1,329 words) - 15:49, 20 December 2023
• HAEM5:NK-large granular lymphocytic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (2,153 words) - 14:35, 13 December 2023
• HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
  ...iginal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1]]. ==Cancer Category / Type==
  17 KB (2,425 words) - 14:21, 13 December 2023
• Anaplastic Large Cell Lymphoma (ALK+/ALK−)
  ...stic large cell lymphoma”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated 12/13/2023, <nowiki>https://ccga.io/inde ...ccur.<ref>Karikari, I.O.; Thomas, K.K.; Lagoo, A.; Cummings, T.J.; George, T.M. Primary Cerebral ALK-1-Positive Anaplastic Large Cell Lymphoma in a Chil
  10 KB (1,484 words) - 22:04, 27 February 2024
• HAEM5:Large B-cell lymphoma with IRF4 rearrangement
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  22 KB (3,020 words) - 14:30, 13 December 2023
• HAEM5:Sezary syndrome
  ==Cancer Category / Type== Mature T-cell neoplasm / Cutaneous T-cell lymphoma
  19 KB (2,695 words) - 14:39, 13 December 2023
• HAEM5:Langerhans cell sarcoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  14 KB (1,883 words) - 14:30, 13 December 2023
• HAEM5:Juvenile myelomonocytic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,607 words) - 14:29, 13 December 2023
• GATA2
  ==Cancer Category/Type== Non-small cell lung cancer (NSCLC)
  12 KB (1,650 words) - 14:21, 12 December 2023
• HAEM5:Acute undifferentiated leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  16 KB (2,259 words) - 14:18, 13 December 2023
• HAEM5:Hepatosplenic T-cell lymphoma
  {{DISPLAYTITLE:Hepatosplenic T-cell lymphoma}} ...ate on 2023-12-07. The original page can be found at [[HAEM4:Hepatosplenic T-cell Lymphoma]].
  22 KB (3,064 words) - 14:26, 13 December 2023
• HAEM5:Acute megakaryoblastic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  17 KB (2,355 words) - 14:16, 13 December 2023
• BRST5:Phyllodes Tumour
  ==Cancer Category / Type== Breast cancer / Fibroepithelial Tumors of the Breast
  16 KB (2,255 words) - 13:27, 29 February 2024
• HAEM5:In situ follicular B-cell neoplasm
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  14 KB (1,944 words) - 14:27, 13 December 2023
• ASXL1
  ==Cancer Category/Type== Colorectal cancer
  13 KB (1,790 words) - 18:29, 5 January 2019
• HAEM5:Systemic mastocytosis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  16 KB (2,262 words) - 14:40, 13 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  14 KB (2,044 words) - 10:09, 27 February 2024
• Giant cell glioblastoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  14 KB (1,866 words) - 11:58, 13 April 2020
• HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion
  ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214]]. [[File:T(6;9)(p23;q34).png]]
  19 KB (2,611 words) - 14:17, 13 December 2023
• HAEM5:Mixed-phenotype acute leukaemia with KMT2A rearrangement
  ...al page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]]. ==Cancer Category / Type==
  19 KB (2,659 words) - 14:32, 13 December 2023
• HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion
  ...can be found at [[HAEM4:Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]]. ==Cancer Category / Type==
  18 KB (2,546 words) - 14:17, 13 December 2023
• HAEM5:Langerhans cell histiocytosis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (1,965 words) - 14:30, 13 December 2023
• HAEM5:Myeloid/lymphoid neoplasm with PDGFRB rearrangement
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,652 words) - 14:34, 13 December 2023
• HAEM5:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis
  ...liferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]]. ==Cancer Category / Type==
  18 KB (2,549 words) - 14:33, 13 December 2023
• HAEM5:Mixed-phenotype acute leukaemia, B/myeloid
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  17 KB (2,372 words) - 14:31, 13 December 2023
• HAEM5:Nodal marginal zone lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,651 words) - 14:36, 13 December 2023
• HAEM5:Indolent T-cell lymphoma of the gastrointestinal tract
  {{DISPLAYTITLE:Indolent T-cell lymphoma of the gastrointestinal tract}} ...template on 2023-12-07. The original page can be found at [[HAEM4:Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]].
  20 KB (2,747 words) - 14:28, 13 December 2023
• HAEM5:Splenic diffuse red pulp small B-cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,651 words) - 14:40, 13 December 2023
• HAEM5:Acute monocytic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  17 KB (2,307 words) - 14:16, 13 December 2023
• HAEM5:Breast implant-associated anaplastic large cell lymphoma
  ==Cancer Category / Type== * [[HAEM4:Mature T- and NK-cell Neoplasms]]
  19 KB (2,622 words) - 14:21, 13 December 2023
• HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma
  {{DISPLAYTITLE:Monomorphic epitheliotropic intestinal T-cell lymphoma}} ...iginal page can be found at [[HAEM4:Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]].
  19 KB (2,721 words) - 14:32, 13 December 2023
• HAEM5:Myeloid/lymphoid neoplasm with JAK2 rearrangement
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  20 KB (2,830 words) - 14:34, 13 December 2023
• DNMT3A
  ==Cancer Category/Type== *T-cell acute lymphoblastic leukaemia (T-ALL)
  14 KB (1,939 words) - 18:10, 5 January 2019
• HAEM5:Lymphoplasmacytic lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (2,015 words) - 14:30, 13 December 2023
• CNS5:Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  17 KB (2,350 words) - 13:52, 25 February 2024
• HAEM5:Acute basophilic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,722 words) - 14:16, 13 December 2023
• HAEM5:Acute myeloid leukaemia with KMT2A rearrangement
  ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]]. ==Cancer Category / Type==
  21 KB (2,953 words) - 14:17, 13 December 2023
• HAEM5:Classic Hodgkin lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  15 KB (2,067 words) - 14:23, 13 December 2023
• HAEM5:Primary cutaneous follicle centre lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,639 words) - 14:38, 13 December 2023
• HAEM5:Splenic B-cell lymphoma/leukaemia with prominent nucleoli
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  22 KB (2,984 words) - 14:40, 13 December 2023
• HAEM5:High grade B-cell lymphoma with 11q aberrations
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  25 KB (3,405 words) - 14:26, 13 December 2023
• HAEM5:Mixed-phenotype acute leukaemia, T/myeloid
  {{DISPLAYTITLE:Mixed-phenotype acute leukaemia, T/myeloid}} ...iginal page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]].
  19 KB (2,751 words) - 14:31, 13 December 2023
• HAEM5:Polycythaemia vera
  UT MD Anderson Cancer Center ==Cancer Category / Type==
  21 KB (2,945 words) - 14:37, 13 December 2023
• HAEM5:Mixed-phenotype acute leukaemia with BCR::ABL1 fusion
  ...al page can be found at [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]]. ==Cancer Category / Type==
  21 KB (2,942 words) - 14:31, 13 December 2023
• HAEM5:Mast cell sarcoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,703 words) - 14:31, 13 December 2023
• HAEM5:Myeloproliferative neoplasm, NOS
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  21 KB (2,920 words) - 14:35, 13 December 2023
• B-ALL Tables: Prognostic Genomic Abnormalities and Recurrent Gene Fusions
  ...able derived from Akkari et al., 2020 [PMID 32302940] with permission from Cancer Genetics. All percentages are approximate. |t(12;21)(p13;q22); [[ETV6]]-[[RUNX1]]*
  33 KB (4,848 words) - 10:50, 26 July 2021
• HAEM5:Acute myeloid leukaemia, myelodysplasia-related
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  22 KB (3,114 words) - 14:16, 13 December 2023
• HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma
  {{DISPLAYTITLE:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell ==Cancer Category / Type==
  23 KB (3,154 words) - 14:37, 13 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  24 KB (3,252 words) - 14:20, 13 December 2023
• HAEM5:Gamma heavy chain disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  22 KB (3,077 words) - 14:26, 13 December 2023
• IDH2
  ==Cancer Category/Type== * Angioimmunoblastic T-cell lymphoma
  20 KB (2,671 words) - 14:44, 10 August 2018
• CNS5:Diffuse hemispheric glioma, H3 G34-mutant
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,643 words) - 13:51, 25 February 2024
• HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  21 KB (2,981 words) - 14:18, 13 December 2023
• HAEM5:Myeloid sarcoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  20 KB (2,857 words) - 14:35, 13 December 2023
• HAEM5:ALK-positive large B-cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  19 KB (2,638 words) - 14:16, 13 December 2023
• HAEM5:Aggressive NK-cell leukaemia
  ==Cancer Category / Type== Mature T- and NK-cell neoplasms
  21 KB (2,919 words) - 14:19, 13 December 2023
• HAEM5:T-large granular lymphocytic leukaemia
  {{DISPLAYTITLE:T-large granular lymphocytic leukaemia}} ...the new template on 2023-12-07. The original page can be found at [[HAEM4:T-cell Large Granular Lymphocytic Leukemia]].
  22 KB (3,037 words) - 14:41, 13 December 2023
• SRSF2
  ==Cancer Category/Type== ...scular endothelial growth factor (''VEGF'') (Merdzhanova et al., 2010). In cancer, ''SRSF2'' variants have been implicated in leukemia and myeloid disorders
  16 KB (2,281 words) - 14:50, 12 December 2023
• HAEM5:Acute erythroid leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  22 KB (3,152 words) - 14:16, 13 December 2023
• Testpage2
  .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
  23 KB (3,285 words) - 15:49, 13 September 2019
• AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray
  .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
  23 KB (3,285 words) - 16:56, 8 August 2020
• TestAMLtable
  .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
  23 KB (3,282 words) - 11:49, 14 June 2019
• HAEM5:Myelodysplastic neoplasm with low blasts and 5q deletion
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  27 KB (3,890 words) - 14:33, 13 December 2023
• HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion
  ...he original page can be found at [[HAEM4:Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]]. ==Cancer Category / Type==
  29 KB (4,172 words) - 14:17, 13 December 2023
• BRST5:Adenoid Cystic Carcinoma
  ==Cancer Category/Type== Breast Cancer / Epithelial Tumours of the Breast
  19 KB (2,737 words) - 13:17, 29 February 2024
• HAEM5:Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  27 KB (3,639 words) - 14:37, 13 December 2023
• HAEM5:Chronic eosinophilic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  21 KB (2,967 words) - 14:22, 13 December 2023
• HAEM5:Myelodysplastic neoplasm with increased blasts
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  21 KB (2,936 words) - 14:33, 13 December 2023
• HAEM5:Acute myeloid leukaemia with MECOM rearrangement
  ...e found at [[HAEM4:Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]]. [[File:t(3;3)(q21;q26.2).png|t(3;3)(q21;q26.2)]]
  25 KB (3,672 words) - 14:17, 13 December 2023
• HAEM5:Myelodysplastic/myeloproliferative neoplasm, NOS
  Victorian Cancer Cytogenetics Service ==Cancer Category / Type==
  28 KB (3,984 words) - 14:32, 13 December 2023
• HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  26 KB (3,785 words) - 14:16, 13 December 2023
• HAEM5:Myelodysplastic/myeloproliferative neoplasm with neutrophilia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  24 KB (3,323 words) - 14:33, 13 December 2023
• HAEM5:Paediatric nodal marginal zone lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  27 KB (3,643 words) - 14:36, 13 December 2023
• TET2
  ==Cancer Category/Type== ...ET2 and WT1 physically interact, suggesting overlapping pathways for these genes in AML (Wang et al., 2015). ''TET2'' mutations increase the response of low
  26 KB (3,824 words) - 15:01, 12 December 2023
• HAEM5:Adult T-cell leukaemia/lymphoma
  {{DISPLAYTITLE:Adult T-cell leukaemia/lymphoma}} ...ew template on 2023-12-07. The original page can be found at [[HAEM4:Adult T-cell Leukemia/Lymphoma]].
  30 KB (4,300 words) - 14:18, 13 December 2023
• HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  26 KB (3,527 words) - 14:25, 13 December 2023
• HAEM5:Childhood myelodysplastic neoplasm with increased blasts
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  24 KB (3,361 words) - 14:22, 13 December 2023
• HAEM5:Childhood myelodysplastic neoplasm with low blasts
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  24 KB (3,361 words) - 14:22, 13 December 2023
• HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  30 KB (4,118 words) - 14:20, 13 December 2023
• HAEM5:High-grade B-cell lymphoma, NOS
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  26 KB (3,680 words) - 14:26, 13 December 2023
• HAEM5:Paediatric-type follicular lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  28 KB (3,914 words) - 14:36, 13 December 2023
• MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray
  ...ed from Kanagal-Shawanna et al., 2018 [PMID 30377088] with permission from Cancer Genetics. ...urvival in a cohort of MDS or AML patients treated with azacitidine. Blood Cancer J 2013;3:e155.[https://www.ncbi.nlm.nih.gov/pubmed/24185502]</ref><ref name
  38 KB (5,270 words) - 17:10, 30 April 2020
• HAEM5:Acute myeloid leukaemia with CEBPA mutation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  29 KB (4,102 words) - 14:17, 13 December 2023
• BRST5:Inflammatory Myofibroblastic Tumour
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  22 KB (3,074 words) - 13:28, 29 February 2024
• HAEM5:Splenic marginal zone lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  32 KB (4,341 words) - 14:40, 13 December 2023
• HAEM5:Myeloid/lymphoid neoplasm with FGFR1 rearrangement
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  40 KB (5,552 words) - 14:34, 13 December 2023
• WT1
  ==Cancer Category/Type== ===Role in Cancer===
  20 KB (2,904 words) - 03:02, 13 August 2018
• HAEM5:Chronic neutrophilic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  26 KB (3,703 words) - 14:23, 13 December 2023
• Clear cell renal cell carcinoma
  Cancer Metastasis Rev (2014) 33:1109–1124 PMID:[http://www.ncbi.nlm.nih.gov/pubm ...gnature PI3K/AKT and mTOR pathways elevated; high expression of several genes representing targets for immunotherapy including PDCD1, CD247, PDCD1LG2, CT
  8 KB (1,050 words) - 16:48, 19 August 2016
• HAEM5:Blastic plasmacytoid dendritic cell neoplasm
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  26 KB (3,637 words) - 14:21, 13 December 2023
• HAEM5:Myeloid proliferations associated with Down syndrome
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  25 KB (3,458 words) - 14:35, 13 December 2023
• HAEM5:Cutaneous mastocytosis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  22 KB (3,137 words) - 10:13, 27 February 2024
• STBT5:Solitary fibrous tumour
  !Chromosomal Rearrangement!!Genes in Fusion (5’ or 3’ Segments)!!Pathogenic Derivative!!Prevalence ...linelibrary.wiley.com/doi/10.1002/gcc.22083|journal=Genes, Chromosomes and Cancer|language=en|volume=52|issue=10|pages=873–886|doi=10.1002/gcc.22083|issn=1
  21 KB (3,051 words) - 07:55, 22 April 2024
• Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations
  ...Table derived from Pugh et al., 2018 [PMID 30393007] with permission from Cancer Genetics. |'''Genes'''
  17 KB (2,298 words) - 16:42, 22 April 2021
• HAEM5:Hairy cell leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  26 KB (3,699 words) - 14:26, 13 December 2023
• HAEM5:Systemic EBV-positive T-cell lymphoma of childhood
  {{DISPLAYTITLE:Systemic EBV-positive T-cell lymphoma of childhood}} ...023-12-07. The original page can be found at [[HAEM4:Systemic EBV-Positive T-cell Lymphoma of Childhood]].
  26 KB (3,630 words) - 14:40, 13 December 2023
• HAEM5:ALK-negative anaplastic large cell lymphoma
  ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]
  32 KB (4,584 words) - 14:16, 13 December 2023
• HAEM5:Enteropathy-associated T-cell lymphoma
  {{DISPLAYTITLE:Enteropathy-associated T-cell lymphoma}} ...23-12-07. The original page can be found at [[HAEM4:Enteropathy-Associated T-cell Lymphoma]].
  31 KB (4,371 words) - 14:25, 13 December 2023
• HAEM5:Chronic myeloid leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  29 KB (4,258 words) - 14:22, 13 December 2023
• GTS5:Neurofibromatosis type 1 (NF1)
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  21 KB (2,978 words) - 13:33, 25 February 2024
• HAEM5:Plasmablastic lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  29 KB (3,951 words) - 14:37, 13 December 2023
• HAEM5:Myeloid/lymphoid neoplasm with PDGFRA rearrangement
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  34 KB (4,742 words) - 14:34, 13 December 2023
• HAEM5:Acute myeloid leukaemia with minimal differentiation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  27 KB (3,828 words) - 14:18, 13 December 2023
• HAEM5:Nodal TFH cell lymphoma, angioimmunoblastic-type
  ...n 2023-12-07. The original page can be found at [[HAEM4:Angioimmunoblastic T-cell Lymphoma]]. ==Cancer Category / Type==
  34 KB (4,909 words) - 14:35, 13 December 2023
• HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  34 KB (4,782 words) - 16:37, 20 December 2023
• Testpage5
  ==Cancer Category/Type== [[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
  22 KB (3,117 words) - 15:04, 12 December 2023
• HAEM5:Monoclonal immunoglobulin deposition disease
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  27 KB (3,735 words) - 14:32, 13 December 2023
• HAEM5:Acute myeloid leukaemia with NPM1 mutation
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  31 KB (4,299 words) - 14:17, 13 December 2023
• Testpage4
  ==Cancer Category/Type== [[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
  24 KB (3,522 words) - 15:04, 12 December 2023
• HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion
  ...be found at [[HAEM4:Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]]. ==Cancer Category / Type==
  30 KB (4,324 words) - 14:16, 13 December 2023
• CNS5:Ganglioglioma
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  23 KB (3,102 words) - 13:55, 25 February 2024
• HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  28 KB (3,970 words) - 14:19, 13 December 2023
• HAEM5:Early T-precursor lymphoblastic leukaemia / lymphoma
  {{DISPLAYTITLE:Early T-precursor lymphoblastic leukaemia / lymphoma}} ...ew template on 2023-12-07. The original page can be found at [[HAEM4:Early T-Cell Precursor Lymphoblastic Leukemia]].
  25 KB (3,503 words) - 14:24, 13 December 2023
• HAEM5:Burkitt lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  33 KB (4,726 words) - 14:22, 13 December 2023
• ACMG technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders (2013)
  ...somal abnormalities identified by standard methods has led to discovery of genes, and gene function and dysfunction. This knowledge has led to improved ther ..., et al.; Adult Leukaemia Working Party, Medical Research Council/National Cancer Research Institute. Karyotype is an independent prognostic factor in adult
  59 KB (8,449 words) - 19:11, 27 July 2016
• HAEM5:Mycosis fungoides
  ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]
  42 KB (5,916 words) - 14:32, 13 December 2023
• HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  40 KB (5,683 words) - 14:36, 13 December 2023
• IDH1
  ==Cancer Category/Type== * Prostate cancer
  38 KB (5,062 words) - 12:33, 10 August 2018
• CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH
  ...Table derived from Chun et al., 2018 [PMID 30554732] with permission from Cancer Genetics. |'''Relevant Genes'''
  40 KB (5,707 words) - 22:25, 7 November 2020
• HAEM5:Essential thrombocythaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  34 KB (4,834 words) - 14:25, 13 December 2023
• HAEM5:Chronic myelomonocytic leukaemia
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  31 KB (4,295 words) - 14:22, 13 December 2023
• HAEM5:Myelodysplastic neoplasm with biallelic TP53 inactivation
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  39 KB (5,484 words) - 14:43, 20 December 2023
• HAEM5:Immunoglobulin-related (AL) amyloidosis
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  48 KB (6,794 words) - 14:27, 13 December 2023
• HAEM5:Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  56 KB (7,988 words) - 14:24, 13 December 2023
• HAEM5:Mantle cell lymphoma
  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas ==Cancer Category / Type==
  41 KB (5,923 words) - 14:31, 13 December 2023
• HAEM5:Histiocytic sarcoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  42 KB (6,120 words) - 14:27, 13 December 2023
• EZH2
  ==Cancer Category/Type== '''Natural Killer/T-cell Lymphoma'''
  36 KB (5,335 words) - 14:18, 12 December 2023
• HAEM5:Intravascular large B-cell lymphoma
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  55 KB (7,745 words) - 14:29, 13 December 2023
• CNS5:Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
  ..., MS, Neuropathology Fellow Houston Methodist/Texas Children’s/MD Anderson Cancer Center ==Cancer Category/Type==
  36 KB (5,058 words) - 13:49, 25 February 2024
• HAEM5:In situ mantle cell neoplasm
  ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==
  52 KB (7,572 words) - 14:28, 13 December 2023
• CNS5:Medulloblastoma, WNT-activated
  ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
  31 KB (4,325 words) - 13:55, 25 February 2024
• Cancer Types
  ::T-cell and NK/T-cell lymphomas ::Mismatch repair cancer syndrome
  38 KB (3,868 words) - 13:56, 12 December 2023
• HAEM5:ALK-positive anaplastic large cell lymphoma
  ==Cancer Category / Type== *[[HAEM4:Mature T- and NK-cell Neoplasms]]
  64 KB (9,095 words) - 14:16, 13 December 2023
• Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations
  ...Table derived from Liu et al., 2020 [PMID 32434132] with permission from Cancer Genetics. ...ehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer|url=https://pubmed.ncbi.nlm.nih.gov/23083876|journal=The Journal of Urology
  42 KB (5,820 words) - 13:40, 19 May 2021
• HAEM5:Volunteer Assignments and Opportunities
  |Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center |T. Niroshi Senaratne, UCLA
  61 KB (7,864 words) - 16:23, 16 April 2024
• Somatically Mutated Genes
  ...ist is based on the 2016 [http://cancer.sanger.ac.uk/census/ Sanger Centre Cancer Gene Census]. | [[ABL1]] || 9q34.1 || [[CML]],[[ALL]],[[T-ALL]] || [[BCR]],[[ETV6]],[[NUP214]]
  38 KB (4,038 words) - 18:34, 17 July 2016
• HAEM5:Plasma cell myeloma / multiple myeloma
  The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas ==Cancer Category / Type==
  80 KB (11,414 words) - 14:36, 13 December 2023
• Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray
  ...://pubmed.ncbi.nlm.nih.gov/32203924/ PMID: 32203924]] with permission from Cancer Genetics. ...ilocytic astrocytomas|url=https://pubmed.ncbi.nlm.nih.gov/18974108|journal=Cancer Research|volume=68|issue=21|pages=8673–8677|doi=10.1158/0008-5472.CAN-08-
  103 KB (13,991 words) - 17:05, 20 April 2021

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)